| Geld/Brief | 21,07 $ / 25,36 $ |
| Spread | +20,36% |
| Schluss Vortag | 23,67 $ |
| Gehandelte Stücke | 72.736 |
| Tagesvolumen Vortag | 986.513,9 $ |
| Tagestief 23,30 $ Tageshoch 23,91 $ | |
| 52W-Tief - 52W-Hoch 23,52 $ | |
| Jahrestief 10,29 $ Jahreshoch 24,53 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -371,64 $ |
| Jahresüberschuss in Mio. | -695,98 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -70,50 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -149,96% |
| Marktkapitalisierung in Mio. | 1.344 $ |
| KGV (Kurs/Gewinn) | -0,19 |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | -35,40% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 23,64 $ | -0,25% | 23,70 $ | 27.08.26 | |
| Nasdaq | 23,52 $ | -0,63% | 23,67 $ | 27.08.26 | |
| NYSE | 23,54 $ | -0,80% | 23,73 $ | 27.08.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 27.08.26 | 23,52 | 0,99 M |
| 26.08.26 | 23,67 | 0,92 M |
| 25.08.26 | 24,01 | 8,02 M |
| 24.08.26 | 22,71 | 1,23 M |
| 21.08.26 | 23,36 | 2,33 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 23,065 $ | +1,97% |
| 1 Monat | 19,44 $ | +20,99% |
| 6 Monate | 15,43 $ | +52,43% |
| 1 Jahr | - | - |
| 5 Jahre | - | - |
| Marktkapitalisierung | 1,34 Mrd. $ |
| Streubesitz | 20,45% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +10,47% | TCG Crossover Management, LLC |
| +9,97% | RA Capital Management, LLC |
| +7,60% | FCPM III SERVICES BV |
| +5,61% | VR Adviser, LLC |
| +4,69% | Frazier Life Sciences Management, L.P. |
| +3,55% | Caligan Partners LP |
| +3,23% | Paradigm Biocapital Advisors LP |
| +3,23% | Great Point Partners LLC |
| +3,22% | State Street® SPDR® S&P® Biotech ETF |
| +2,86% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,85% | Vanguard MStar Total Stk Mkt Idx Invest |
| +2,84% | FMR Inc |
| +2,65% | Vanguard Capital Management, LLC |
| +2,54% | Fidelity Select Biotechnology |
| +2,13% | Marshall Wace Asset Management Ltd |
| +2,06% | State Street Corp |
| +1,95% | iShares Russell 2000 ETF |
| +1,85% | NEXTBio Capital Management LP |
| +1,47% | BlackRock Inc |
| +1,38% | Logos Global Management LP |
| +1,29% | Rosalind Advisors, Inc. |
| +1,19% | NAN FUNG TRINITY (HK) Ltd |
| +1,03% | BOOTHBAY FUND MANAGEMENT, LLC |
| +1,00% | Fidelity Small Cap Growth |
| +0,91% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,90% | UBS Group AG |
| +0,86% | BRAIDWELL LP |
| +0,51% | Franklin Biotechnology Discv A(acc)USD |
| +0,51% | Fidelity Small Cap Growth K6 |
| +0,48% | iShares Russell 2000 Growth ETF |
| +0,48% | Russell 2000 Index Non-Lendable Fund |
| +0,48% | Russell 2000 Equity Index Fund B |
| +0,44% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,43% | Vanguard Russell 2000 ETF |
| +0,34% | Fidelity Advisor Biotechnology I |
| +0,29% | Fidelity Extended Market Index |
| +0,28% | State St Russell Sm Cap® Idx SL Cl I |
| +0,27% | Franklin Biotechnology Discovery A |
| +0,27% | Bridge Builder Small/Mid Cap Growth |
| +0,26% | iShares Micro-Cap ETF |
| +0,21% | iShares Russell 2000 Value ETF |
| +0,21% | BlackRock Health Sciences Opps Inv A |
| +0,19% | Fidelity Enhanced Small Cap Core ETF |
| +0,19% | Rhenman Healthcare Equity L/S RC2 SEK |
| +75,281% | Institutionelle Aktionäre |
| +4,271% | Insider Aktionäre |
| +20,448% | Streubesitz |